Follicum receives preliminary approval for patent application in Europe for extended protection of product candidate FOL-005
Follicum announced today that it has received an Intention to grant from the European Patent Office (EPO) regarding its patent application No. 16169698.4 which protects the product candidate FOL-005.In this patent family, Follicum has already a granted product patent in Europe that specifically covers FOL-005. Follicum has subsequently submitted a follow-up, a so called "Divisional" application, which extends and broadens the protection around FOL-005. Follicum has now received a preliminary approval for this divisional application. The patent covers the drug candidate FOL-005 and related